EPCAM and cancer: In cancer tissue, the subcellular distribution of EpCAM is changed from the basolateral location to a homogeneously dispersed pattern on cancer cell surface, making the molecule easily accessible to cellular and antibody-based immunotherapy [1, 3, 4, 8–10]